← Back to Clinical Trials
Recruiting NCT07153458

NCT07153458 Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07153458
Status Recruiting
Phase —
Sponsor Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Condition CRC (Colorectal Cancer)
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2025-12-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study in question is an observational study that aims to identify new non-invasive biomarkers present in the serum of patients with CRC and, subsequently, to create a score capable of predicting the development of CRC. It is an observational study with 3 enrollment arms: Arm 1: Patients undergoing surgery at the U.O.C. of Surgery, with a CRC diagnosis; Arm 2: Subjects with a negative result from the endoscopic examination; Arm 3: Subjects in whom the presence of an adenoma with high-grade dysplasia is found, a condition considered pre-cancerous.

Eligibility Criteria

Inclusion Criteria: * AIM 1: Patients undergoing surgery at the U.O.C. of Surgery, with a diagnosis of CRC. * AIM 2: Subjects without colon disease. * AIM 3: Subjects with adenoma and high-grade dysplasia. Exclusion Criteria: * Subject with any other pathology not included in the inclusion criteria.

Contact & Investigator

Central Contact

Pasqua Letizia Pesole, Biologist

✉ letizia.pesole@irccsdebellis.it

📞 +390804994365

Frequently Asked Questions

Who can join the NCT07153458 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying CRC (Colorectal Cancer). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07153458 currently recruiting?

Yes, NCT07153458 is actively recruiting participants. Contact the research team at letizia.pesole@irccsdebellis.it for enrollment information.

Where is the NCT07153458 trial being conducted?

This trial is being conducted at Castellana Grotte, Italy.

Who is sponsoring the NCT07153458 clinical trial?

NCT07153458 is sponsored by Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology